Every date and figure for Indoco Remedies Limited is sourced directly from NSE board-meeting intimations and the official filings the company submits once results are declared. We don't estimate, guess, or backfill missing data. View the most recent filing ↗
| Period | Revenue | Net profit | EPS | Net margin | Source |
|---|---|---|---|---|---|
| Q1 FY27Latest28 Jul 2026 | ₹409 cr | ₹82 cr | ₹8.92 | 20.1% | Filing ↗ |
Consensus estimates aren't connected to a live production feed yet. This is a feature-availability notice, not a loading error.
This company has no recorded board-meeting filings yet.
Shareholders meeting
View filing ↗This company has no recorded corporate-action filings yet.
This company has no recorded dividend payouts.
Revenue mix isn't wired to a live filings feed in production yet — this isn't a loading error.
| Company | Mkt cap | Latest rev | EPS | Net margin |
|---|---|---|---|---|
APL Alembic Pharmaceuticals LimitedAPLLTD · NSE | — | ₹1,868 cr | ₹10.02 | 10.5% |
AST AstraZeneca Pharma India LimitedASTRAZEN · NSE | — | ₹683 cr | ₹15.17 | 5.6% |
AUR Aurobindo Pharma LimitedAUROPHARMA · NSE | — | — | — | — |
BAL Bal Pharma LimitedBALPHARMA · NSE | — | ₹88 cr | ₹0.73 | 1.3% |
BLI Bliss GVS Pharma LimitedBLISSGVS · NSE | — | ₹222 cr | ₹3.65 | 17.4% |
BIO Biocon LimitedBIOCON · NSE | — | ₹625 cr | ₹0.32 | 8.4% |
BRO Brooks Laboratories LimitedBROOKS · NSE | — | ₹23 cr | ₹0.48 | 6.2% |
AAR Aarti Drugs LimitedAARTIDRUGS · NSE | — | ₹627 cr | ₹5.57 | 8.1% |
This company has no recorded face-value sub-divisions.